These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 6171643)

  • 21. Suppressor cell numbers and activity in non-transfused renal dialysis patients.
    Smith MD; Hardy G; Williams JD; Coles GA
    Clin Nephrol; 1983 Sep; 20(3):130-5. PubMed ID: 6226465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppressor cell activity in progressive systemic sclerosis.
    Krawitt EL; Holdstock G; Bland JH; Chastenay BF; Albertini RJ
    J Rheumatol; 1982; 9(2):263-7. PubMed ID: 6212678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of immune response in allogeneic mixed spleen cell cultures. I. Influence of I-region on the generation of suppressor cells.
    Kim YT; Schwartz A; Moody C; Siskind GW; Weksler ME
    J Immunol; 1980 Oct; 125(4):1724-9. PubMed ID: 6447730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Con A suppressor cell assay: a further characterization.
    Meroni PL; Balestrieri G; Barcellini W; DeBartolo G; Fenini G; Tincani A; Zanussi C
    J Clin Lab Immunol; 1983 Mar; 10(3):159-63. PubMed ID: 6221109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of suppressor cells in the autologous mixed lymphocyte reaction.
    Fitzharris P; Knight RA
    Clin Exp Immunol; 1981 Oct; 46(1):185-95. PubMed ID: 6461452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soluble antigen-primed inducer T cells activate antigen-specific suppressor T cells in the absence of antigen-pulsed accessory cells: phenotypic definition of suppressor-inducer and suppressor-effector cells.
    Damle NK; Mohagheghpour N; Engleman EG
    J Immunol; 1984 Feb; 132(2):644-50. PubMed ID: 6197471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recognition of PSA-derived peptide antigens by T cells from prostate cancer patients without any prior stimulation.
    Chakraborty NG; Stevens RL; Mehrotra S; Laska E; Taxel P; Sporn JR; Schauer P; Albertsen PC
    Cancer Immunol Immunother; 2003 Aug; 52(8):497-505. PubMed ID: 12783216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The accessory cell function of human alveolar macrophages in specific T cell proliferation.
    Toews GB; Vial WC; Dunn MM; Guzzetta P; Nunez G; Stastny P; Lipscomb MF
    J Immunol; 1984 Jan; 132(1):181-6. PubMed ID: 6228577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The presence of dominant T-cell clones in peripheral blood of patients with collagen vascular disorders: a prospective study of 97 cases.
    Dereure O; Gubler B; Bessis D; Guillot B; Guilhou JJ; Clot J; Eliaou JF
    Br J Dermatol; 2006 Mar; 154(3):445-9. PubMed ID: 16445773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of in vitro antigen exposure upon suppressor cell function in atopic disease.
    Church JA; Nye C
    Ann Allergy; 1982 Apr; 48(4):199-204. PubMed ID: 6176149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depressed primary in vitro antibody response in untreated systemic lupus erythematosus. T helper cell defect and lack of defective suppressor cell function.
    Delfraissy JF; Segond P; Galanaud P; Wallon C; Massias P; Dormont J
    J Clin Invest; 1980 Jul; 66(1):141-8. PubMed ID: 6447163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Function of monocytes in patients with systemic sclerosis.
    Czirják L; Dankó K; Zeher M; Lukács K; Szegedi G
    Acta Med Hung; 1988; 45(1):53-61. PubMed ID: 3045745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T cell lines from systemic sclerosis patients and healthy controls recognize multiple epitopes on DNA topoisomerase I.
    Hu PQ; Oppenheim JJ; Medsger TA; Wright TM
    J Autoimmun; 2006 Jun; 26(4):258-67. PubMed ID: 16735104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of suppressor cells for natural killer activity in cancer patients after surgery.
    Uchida A; Kolb R; Micksche M
    J Natl Cancer Inst; 1982 May; 68(5):735-41. PubMed ID: 6461792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of primary antibody response in mice by two types of suppressor cells resistant to anti-thy-1 serum treatment.
    Hirokawa K; Hatakeyama S; Sado T
    Bull Tokyo Med Dent Univ; 1981 Sep; 28(3):99-109. PubMed ID: 6456846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MLC-specific suppressor T lymphocytes in man. I. Their induction in vitro by soluble HLA-DR antigens.
    Smeraldi RS; Fabio G; Bonara P; Villa MG; Vanoli M; Pettenati C; Rugarli C; Zanussi C
    J Immunol; 1982 Mar; 128(3):1394-8. PubMed ID: 6173435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro interaction with antigen suppresses the differentiation of chronic lymphocytic leukemia cells secreting monoclonal anti-sheep red blood cell antibody.
    Fiorilli M; Misiti J; Pandolfi F; Semenzato G; Waldmann TA
    J Immunol; 1983 Oct; 131(4):2046-9. PubMed ID: 6225803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppressor T cells for delayed-type hypersensitivity to Japanese encephalitis virus.
    Mathur A; Rawat S; Chaturvedi UC
    Immunology; 1984 Jul; 52(3):395-402. PubMed ID: 6204929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppressor cell activity in patients with rheumatoid arthritis.
    Smolen JS; Lanzer G; Scherak O; Menzel EJ; Steffen C; Knapp W
    Agents Actions Suppl; 1980; 7():204-7. PubMed ID: 6454336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased suppressor T cell activity in patients with hepatic cirrhosis (HC).
    Tomino S; Fujiwara H; Kagimoto T; Mitsuya H; Nishimura H; Kishimoto S
    Clin Exp Immunol; 1982 Jun; 48(3):625-32. PubMed ID: 6214341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.